1.Meta-analysis of the efficacy and safety of CD19 CAR-T cell therapy versus standard treatment for relapsed/refractory diffuse large B-cell lymphoma
LEI Qi1 ; MA Chendong2 ; XIONG Shufeng1 ; SUN Yu1 ; HAN Linlin1 ; GU Zhenyang3 ; DONG Lili1
Chinese Journal of Cancer Biotherapy 2026;33(5):563-569
[摘 要] 目的:系统评价CD19 CAR-T细胞免疫疗法对比标准治疗在复发/难治性弥漫性大B细胞淋巴瘤(R/R DLBCL)患者中疗效与安全性,通过探索性分析探索不同CAR-T细胞产品对疗效的潜在影响,为临床治疗决策提供循证参考。方法:计算机检索中国知网、万方数据库、维普期刊数据库、中国生物医学文献数据库、PubMed、Embase和Cochrane Library数据库,搜集CD19 CAR-T细胞疗法对比标准治疗用于R/R DLBCL的随机对照试验(RCT),检索时限均为建库至2025年10月25日。由2位研究者独立进行文献筛选、数据提取和质量评价,采用R4.2.2软件进行Meta分析。结果:共纳入2项Ⅲ期RCT研究(ZUMA-7、TRANSFORM),各结局指标均根据异质性检验结果选择固定效应模型合并数据。疗效方面,CD19 CAR-T细胞疗法可显著改善患者无事件生存期(HR=0.455,95%CI:0.363~0.570,P < 0.001)和降低死亡风险(HR = 0.738,95%CI:0.575~0.947,P = 0.017);同时可显著提高完全缓解率(RR = 1.879,95%CI:1.574~2.242,P < 0.001)。按产品类型的探索性分析显示,liso-cel和axi-cel均优于标准治疗(liso-cel:HR = 0.380,95%CI:0.260~0.540,P < 0.001;axi-cel:HR = 0.510,95%CI:0.380~0.680,P < 0.001),但该分析为不同试验间的对比,证据等级有限。安全性结局显示:CAR-T细胞疗法的免疫效应细胞相关神经毒性综合征(ICANS)发生率显著升高(RR = 22.387,95%CI:4.353~115.132,P < 0.001);≥3级细胞因子释放综合征(CRS)发生率数值升高(RR = 8.181,95%CI:0.935~71.574,P = 0.058),差异无统计学意义。纳入研究的偏倚风险整体为低;敏感性分析证实结果稳健。结论:基于2项RCT的Meta分析结果,CD19 CAR-T细胞(liso-cel/axi-cel)可作为R/R DLBCL二线治疗的选择之一,其疗效优于标准治疗,且特征性不良反应(CRS/ICANS)经规范管理后可控,可根据患者基线状态个体化选择CAR-T细胞产品。本研究证据基础薄弱,上述结论尚需更多高质量、大样本RCT验证。
2.Expression and functional role of COA6 in gastric cancer: regulation of malignant behaviors via the AMPK/mTOR signaling pathway
Yang Dan1 ; Xiong Xinya1,2 ; Sun Hanghang1,2 ; Han Ran3
Chinese Journal of Cancer Biotherapy 2026;33(7):737-745
[摘 要] 目的:探讨细胞色素c氧化酶组装因子6(COA6)在胃癌中的表达特征、临床意义及其对胃癌细胞恶性生物学行为的调控作用与分子机制。方法:通过TIMER 2.0、人类蛋白质图谱(HPA)和UALCAN等公共数据库分析COA6在多种肿瘤组织中的mRNA表达水平及部分蛋白表达信息,并分析其与临床病理特征的关联。构建靶向COA6的敲低和过表达慢病毒载体,分别转染SGC-7901和MGC-803细胞,构建COA6稳定修饰细胞模型。敲低体系设置shCOA6‑1、shCOA6‑2、shCOA6‑3实验组及阴性对照shCOA6-NC组;过表达体系设置COA6过表达(OE)组与空载病毒(Vector)对照组,采用WB法验证各组COA6的敲低与过表达效率。随后,分别采用细胞计数实验检测细胞增殖活性,Transwell实验评价细胞侵袭能力,划痕愈合实验观测细胞迁移能力,Annexin V-FITC/PI双染色流式检测细胞凋亡水平,同时利用WB法检测AMPK/mTOR通路核心蛋白的磷酸化水平。结果:COA6在多种肿瘤中呈异常表达,且其表达水平与胃癌临床分期、病理分级、淋巴结转移及TP53突变状态有关联。功能实验表明,敲低COA6可显著抑制胃癌细胞增殖、侵袭和迁移,并促进凋亡(均P < 0.000 1);而过表达COA6则产生相反效应。机制研究发现,COA6敲低导致p-AMPK表达上调、p-mTOR表达下调,AMPK抑制剂Compound C处理可逆转COA6敲低诱导的p-AMPK升高和p-mTOR降低,提示COA6可能与AMPK活化受抑和mTOR磷酸化增强有关。结论:COA6在胃癌中高表达且与部分临床病理特征有关联,其可能通过调控AMPK/mTOR信号通路促进胃癌细胞增殖、侵袭和迁移,并抑制凋亡。
3.Mechanism of Shenling baizhu san in ameliorating ulcerative colitis via regulating flora metabolism-related proteins and TLR4/NF-κB/NLRP3 inflammatory axis
Jiajia XU ; Yu YOU ; Jiaoman WANG ; Yuhui LIU ; Shiyao CHANG ; Zhixian HE ; Ping LI ; Ziyan WANG ; Wei XIONG ; Fei HAN
China Pharmacy 2026;37(15):1992-1997
OBJECTIVE To investigate the mechanism of Shenling baizhu san (SLBZS) in ameliorating ulcerative colitis (UC). METHODS Mice were randomly divided into normal group, model group, and low-, medium-, high-dose SLBZS groups (3, 6, 12 g/kg), with 10 mice in each group. Except for the normal group, mice in other groups were given free access to 3% dextran sulfate sodium solution for 7 days to establish UC models. Simultaneously, mice in each group were intragastrically administered corresponding medicinal liquid or double-distilled water once a day for consecutive 7 days. After the last administration, the histopathological morphology of colon tissues was observed; the serum levels of inflammatory factors including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-18 were detected; the total bile acid contents in liver, gallbladder and colon tissues were determined; the expression level of NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) in colon tissues was tested. The expression levels of flora metabolism-related proteins [G protein-coupled receptor 41(GPR41),GPR43,farnesoid X receptor (FXR), G protein-coupled bile acid receptor 1 (TGR5), flavin-containing monooxygenase 3 (FMO3), cytochrome P450 family 27 subfamily A member 1 (CYP27A1), CYP7A1] in liver or colon tissues, as well as the proteins related to Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB)/NLRP3 inflammatory axis [TLR4, NF-κB, phosphorylated NF-κB (p-NF-κB), myeloid differentiation factor 88 (MyD88), NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), caspase-1] in colon tissues were measured. RESULTS Compared with the model group, the colon tissue injury and inflammatory cell infiltration were alleviated in medium- and high-dose SLBZS groups. The serum levels of TNF-α, IL-1β and IL-18, total bile acid contents in liver and colon tissues, as well as the protein expression levels of FMO3 and CYP7A1 in liver tissues, TLR4, p-NF-κB, NF-κB, MyD88, NLRP3, ASC and caspase-1 in colon tissues were significantly decreased (P<0.05). Meanwhile, the total bile acid content in gallbladder, the protein expression levels of GPR41 and GPR43 in colon tissues, along with CYP27A1, FXR and TGR5 in liver tissues were significantly increased (P<0.05). CONCLUSIONS SLBZS may relieve colonic inflammatory injury and ameliorate UC by regulating the expression of flora metabolism-related proteins and inhibiting the abnormal activation of TLR4/NF-κB/NLRP3 inflammatory axis.
4.Proteomics and molecular simulation analyses of COX17 involvement in demethylzeylasteral-mediated inhibition of proliferation and invasion of MGC-803 gastric cancer cells
Yang Dan1 ; Xiong Xinya2 ; Liao Conghui2 ; Chen Jie2 ; Sun Hanghang2 ; Han Ran3
Chinese Journal of Cancer Biotherapy 2026;33(8):867-875
[摘 要] 目的:探讨细胞色素c氧化酶铜伴侣蛋白17(COX17)是否参与去甲泽拉木醛(DML)抑制胃癌细胞增殖和侵袭的作用。方法: 采用5、10和20 μmol/L DML处理MGC-803细胞,通过显微镜计数和Transwell实验评价DML对细胞增殖和侵袭的影响;采用非标记定量蛋白质组学比较DML处理组与DMSO组的蛋白表达谱,结合差异表达分析和GO功能富集筛选候选蛋白,并采用Western blotting验证DML处理后COX17蛋白表达变化。分别构建COX17敲低和过表达稳定细胞株,通过细胞计数和Transwell实验评价COX17对MGC-803细胞增殖和侵袭的影响。采用分子对接和50 ns分子动力学模拟分析DML与COX17的潜在结合模式及复合物构象稳定性;进一步通过COX17过表达回复实验评价COX17在DML抑制细胞增殖和侵袭过程中的作用。结果:DML显著抑制MGC-803细胞增殖和侵袭,且随DML浓度升高,抑制作用逐渐增强(均P < 0.000 1)。蛋白质组学共筛选出72个差异表达蛋白,其中21个上调、51个下调;结合差异表达特征、GO功能富集结果及前期研究基础,选取COX17进行后续验证。DML可显著下调MGC-803细胞中COX17蛋白表达(P < 0.000 1)。敲低COX17可抑制细胞增殖和侵袭,过表达COX17则促进上述表型。分子对接提示DML与COX17之间可能存在疏水接触、氢键和盐桥等相互作用,对接评分为−6.8 kcal/mol;分子动力学模拟显示DML-COX17复合物在50 ns模拟过程中整体趋于相对稳定。COX17过表达可部分减弱DML对MGC-803细胞增殖和侵袭的抑制作用(P < 0.01)。结论:DML可抑制MGC-803细胞增殖和侵袭并下调COX17蛋白表达,COX17可能参与DML对胃癌细胞恶性表型的调控。
5.Global epidemiological analysis of the burden of 375 diseases and injuries and 88 risk factors from 1990 to 2023
Mei LIU ; Shiwen XIONG ; Qing WANG ; Han ZHOU ; Junji HE ; Hang ZHENG ; Hanluo LI ; Yanhong WEI ; Xiaoke SHANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(09):1428-1438
Objective To analyze the global pattern, long-term trends, and regional and population heterogeneity in the burden of 375 diseases and injuries and 88 risk factors from 1990 to 2023 using data from the Global Burden of Disease Study 2023 (GBD 2023). Methods Publicly available GBD 2023 estimates were extracted for incidence, deaths, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs), and age-standardized rates at the global level and by socio-demographic index (SDI), GBD region, age group, and sex. Descriptive analysis, ranking comparison, stratified analysis, and trend analysis were performed, and 95% uncertainty interval was used to assess the stability of estimates. Results In 2023, non-communicable diseases were the leading contributor to global DALYs, accounting for 64.39% of DALYs across the three major disease and injury groups (communicable, maternal, neonatal, and nutritional diseases, non-communicable diseases, and injuries), and also had the highest age-standardized DALYs rate. From 1990 to 2023, age-standardized DALYs rates declined for three major disease and injury groups, with estimated annual percentage changes of −2.69%, −0.78%, and −1.47%, respectively. Cardiovascular diseases ranked first by both DALYs and deaths in 2023, whereas respiratory infections and tuberculosis ranked first by incidence. Non-communicable diseases were the leading cause of disease burden across all SDI strata. As the SDI level declined, the burden of communicable, maternal, neonatal, and nutritional diseases, as well as injuries, increased markedly. Behavioral and metabolic risks remained the main contributors to attributable deaths and DALYs. Conclusion From 1990 to 2023, the global burden of disease continues to shift toward non-communicable diseases; however, some regions still face a double burden of infectious, maternal and child, injury-related, and chronic diseases. Integrating deaths, DALYs, YLLs, YLDs, and risk-attributable burden helps identify priority areas for prevention and resource allocation across regions and populations.
6.Analysis of Thalassemia Gene Variants in the Wuhan Region.
Xiao-Fan CHEN ; Yong-Fen XIONG ; Bin-Tao SU ; Jing YU ; Han LI ; Shun WANG
Journal of Experimental Hematology 2025;33(5):1398-1404
OBJECTIVE:
To analyze the distribution of thalassemia (referred to as "thalassemia") gene variant types in the population of the Wuhan area, aiming to provide a genetic basis for the precise prevention and control as well as clinical diagnosis of thalassemia in the Wuhan region.
METHODS:
In this study, 2 133 suspected thalassemia patients and individuals undergoing prenatal screening who visited the Department of Hematology, Obstetrics and Gynecology, Reproductive Medicine, Pediatrics, and Neurology at Wuhan First Hospital from October 2022 to October 2024 were selected as the research subjects. Peripheral blood samples were collected from the patients. The common 27 thalassemia genotypes of α- and β-thalassemia were initially screened using fluorescence PCR melting curve analysis technology. For samples where the fluorescence PCR melting curve results indicated unknown variants or where the clinical phenotype was inconsistent with the common genotypes, Sanger sequencing technology was used for review and verification.
RESULTS:
Among the 2 133 specimens analyzed, common thalassemia gene variants were detected in 210 cases (9.85%, 210/2 133). A total of 156 cases (8.05%, 156/1 938) of thalassemia gene variants were detected in females and 54 cases (27.69%, 54/195) in males. A total of 94 cases (4.41%, 94/2 133) of α-thalassemia were detected, including 46 cases (2.16%, 46/2 133) of silent α-thalassemia, 47 cases (2.20%, 47/2 133) of mild α-thalassemia, and 1 case (0.05%, 1/2 133) of intermediate α-thalassemia. Additionally, 111 cases of β-thalassemia were identified (5.20%, 111/2 133), including 51 cases of β/β+ thalassemia (2.39%, 51/2 133), 59 cases of β/β0 thalassemia (2.77%, 59/2 133), and 1 case of β+/HbE thalassemia (0.05%, 1/2 133). αβ-composite thalassemia gene variants were detected in 5 cases (0.23%, 5/2 133), including 1 complex variant with a genotype of --SEA/αα combined with CD41-42 (-TTCT) and 29(A>G), representing a heterozygous variant of three genotypes. Rare globin gene variants were detected in 3 cases, including HBB:c.60C>T, HBB:c.-146G>T, and HBA2:c.*12G>A.
CONCLUSION
The Wuhan region exhibits a relatively high prevalence of thalassemia genes with notable gender disparities. While maintaining focus on thalassemia screening for females, enhanced males screening efforts and genetic counseling should be implemented in future prevention programs.
Humans
;
Female
;
Male
;
Genotype
;
beta-Thalassemia/genetics*
;
China
;
Thalassemia/genetics*
;
alpha-Thalassemia/genetics*
;
Genetic Variation
7.Analysis and clinical characteristics of SLC26A4 gene mutations in 72 cases of large vestibular aqueduct syndrome.
Yuqing LIU ; Wenyu XIONG ; Yu LU ; Lisong LIANG ; Kejie YANG ; Li LAN ; Wei HAN ; Qing YE ; Min WANG ; Yuan ZHANG ; Fangying TAO ; Zuwei CAO ; Wei HUANG ; Xue YANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(7):603-609
Objective:To explore the genetic and clinical characteristics of Guizhou patients with enlarged vestibular aqueduct(EVA) syndrome through combined SLC26A4 variant analysis and clinical phenotype analysis. Methods:Seventy-two EVA patients underwent comprehensive genetic testing using a multiplex PCR-based deafness gene panel and next-generation sequencing(NGS). The audiological and temporal bone imaging characteristics were compared across mutation subtypes. Results:A total of 27 pathogenic loci of SLC26A4 were detected in 72 patients, including c.919-2A>G in 79.2%(57/72). A novel deletion(c.1703_1707+6del) was discovered. Among 65 cases, truncated mutations were 89.2%(58/65), 52.3%(34/65), 28(43.1%) and 7(10.8%). No significant differences were observed in the midpoint diameter of the vestibular aqueduct and the incidence of incomplete partitioning typeⅡ(IP-Ⅱ) of the cochlea among the three groups of patients. Moreover, there was no difference in the midpoint diameter of different vestibular pipes or the combination with IP-Ⅱ. Conclusion:The most common mutation site of SLC26A4 in EVA patients in Guizhou is c.919-2A>G, though genotype-phenotype correlations remain elusive. The detection of 27 mutation sites and the discovery of new mutation sites suggested the precise diagnostic significance of NGS technology in EVA patients in Guizhou.
Humans
;
Sulfate Transporters
;
Vestibular Aqueduct/abnormalities*
;
Mutation
;
Membrane Transport Proteins/genetics*
;
Hearing Loss, Sensorineural/genetics*
;
Male
;
Female
;
Child
;
Adolescent
;
Child, Preschool
;
Adult
;
Young Adult
;
Phenotype
;
High-Throughput Nucleotide Sequencing
8.Development of an intensive care unit emergency tracheal intubation training course for resident physicians in critical care medicine based on virtual simulation technology
Zhiling ZHAO ; Kuangjian XIONG ; Bin HAN ; Qiang ZHANG ; Qinggang GE
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2025;32(2):217-219
Tracheal intubation in emergency and complex scenarios is difficult for critical care medicine residents.Virtual reality(VR)technology has not been used in the training of tracheal intubation in critical care scenarios in China.This project team has developed an emergency tracheal intubation training system for the intensive care unit(ICU)based on virtual simulation technology,and has obtained the computer software copyright registration certificate from the National Copyright Administration(registration number:2024SR1139484).This system uses a case script of acute respiratory distress syndrome(ARDS)secondary to severe acute pancreatitis,sets the roles of patients,family members,nurses and residents,collects digital resources of ICU rescue scenes,computer-aided design(CAD)drawings,instrument models and equipment photos,models instruments and equipment,and uses PICO 4 Pro VR helmets to display the ICU environment in the virtual scene.The key points of skill assessment include tracheal intubation operation,the ability to interpret laboratory results,the ability to judge diseases and the ability to work in teams.The user center contains 3 submodules,namely,the score center,skill analysis and user management.There are 3 user roles in the system,namely,residents,teachers and administrators.The system can track and record the entire operation process,including video recording and playback,and score and comprehensively evaluate each step,thereby realizing an objective and quantitative training and assessment system.By simulating the three-dimensional clinical operation environment of the ICU,the entire process of real tracheal intubation is fully reproduced.Resident doctors are placed in the ICU rescue scene,focusing on training tracheal intubation skills,the ability of doctor-patient communication,on-the-spot response,and teamwork,which is expected to become an important type of standardized teaching in critical care medicine.
9.Explore the effectiveness of a tracheal intubation training system based on virtual reality technology in cultivating the clinical practice abilities of resident physicians
Qiang ZHANG ; Kuangjian XIONG ; Bin HAN ; Zhiling ZHAO ; Qinggang GE
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2025;32(4):476-480
Objective To explore the effectiveness of a tracheal intubation training system based on virtual reality(VR)technology in cultivating the clinical practice abilities of resident physicians.Methods Twenty-five first-year resident physicians who were enrolled in the residency programme at Peking University Third Hospital from August 2024 to February 2025 were recruited for this study.All participants completed a questionnaire after receiving VR-based intensive care unit(ICU)emergency tracheal intubation training,to share their experiences with the VR technology-based ICU emergency tracheal intubation training and the shortcomings encountered during the process.Results ① General information:a total of 25 resident physician questionnaires were distributed in this study and received 25 valid responses(response rate 100%).Among the 25 residents,there were 15 males(60%)and 10 females(40%),with an average age of(25.3±0.8)years.Clinical experience was categorised as≤1 year 4 residents(16%),>1-3 years 8 residents(32%),>3-<5 years 5 residents(20%)and≥5 years 8 residents(32%).Among them,3 residents(12%)had no prior tracheal intubation experience,while 11(44%)had performed>10 intubations.Prior to this training,3 residents(12%)had received other forms of virtual tracheal intubation training,whereas 22(88%)had not.During traditional tracheal intubation training,18 residents(72%)reported that they monitored heart rate and blood pressure,whereas 7(28%)did not.In real-world emergency tracheal intubation scenarios,21 residents(84%)experienced role confusion.Additionally,23 residents(92%)believed that opportunities for tracheal intubation practice were too limited,17(68%)thought traditional training provided more guidance from instructors,and 15(60%)valued practical operation opportunities more in tracheal intubation training.②VR-based ICU emergency tracheal intubation training experience:23 residents(92%)considered the VR-based ICU emergency tracheal intubation training effective,with 13(52%)believing it to be more effective than traditional training.Furthermore,23 residents(92%)felt that the VR-based training created a more relaxed learning atmosphere,heightened their interest in learning tracheal intubation,and had better future prospects;22 residents(88%)believed that VR technology facilitated a better understanding of the laryngeal structure;24 residents(96%)thought that VR-based training reduced practical operation risks and better simulated real-world conditions;16 residents(64%)were highly satisfied with the VR-based ICU emergency tracheal intubation operating system;24 residents(96%)considered the case scenarios in the VR-based training reasonable.17 residents(68%)believed that VR-based training offered more learning opportunities,and 19 residents(76%)thought it reduced anxiety during the intubation process.③ Disadvantages of VR-based ICU emergency tracheal intubation:9 residents(36%)tended to overlook obtaining family consent before emergency tracheal intubation prior to the training.Regarding interactivity,5 residents(20%)rated it as excellent,9(36%)as average,and 11 residents(44%)believe that the interactivity was poor;22 residents(88%)felt a lack of tactile feedback during practical operations;20 residents(80%)recommended adding more simulated scenarios;11 residents(44%)believed that,compared to traditional training,VR training lacked practical operation opportunities.Additionally,17 residents(68%)experienced discomfort such as dizziness during the operation.Conclusion VR-based intubation training effectively enhances technical proficiency and psychological preparedness in ICU clinicians,particularly in anatomical visualization and risk-controlled rehearsal.
10.Guideline for diagnosis and treatment of infection after internal fixation of closed lower limb fractures in adults (version 2025)
Bobin MI ; Faqi CAO ; Weixian HU ; Wu ZHOU ; Chenchen YAN ; Hui LI ; Yun SUN ; Yuan XIONG ; Jinmi ZHAO ; Qikai HUA ; Xinbao WU ; Xieyuan JIANG ; Dianying ZHANG ; Zhongguo FU ; Dankai WU ; Guangyao LIU ; Guodong LIU ; Tengbo YU ; Jinhai TAN ; Xi CHEN ; Fengfei LIN ; Zhangyuan LIN ; Dongfa LIAO ; Aiguo WANG ; Shiwu DONG ; Gaoxing LUO ; Zhao XIE ; Dong SUN ; Dehao FU ; Yunfeng CHEN ; Changqing ZHANG ; Kun LIU ; Deye SONG ; Yongjun RUI ; Fei WU ; Ximing LIU ; Junwen WANG ; Meng ZHAO ; Biao CHE ; Bing HU ; Chengjian HE ; Guanglin WANG ; Xiao CHEN ; Guandong DAI ; Shiyuan FANG ; Wenchao SONG ; Ming CHEN ; Guanghua GUO ; Yongqing XU ; Lei YANG ; Wenqian ZHANG ; Kun ZHANG ; Xin TANG ; Hua CHEN ; Weiguo XU ; Shuquan GUO ; Yong LIU ; Xiaodong GUO ; Zhewei YE ; Liming XIONG ; Tian XIA ; Hongbin WU ; Qisheng ZHOU ; Mengfei LIU ; Yiqiang HU ; Yanjiu HAN ; Hang XUE ; Kangkang ZHA ; Wei CHEN ; Zhiyong HOU ; Bin YU ; Jiacan SU ; Peifu TANG ; Baoguo JIANG ; Guohui LIU
Chinese Journal of Trauma 2025;41(5):421-432
Postoperative infection of internal fixation of closed fractures the lower limbs in adults represents a devastating complication, characterized by diagnostic challenges, prolonged treatment duration and high disability rates. Current management of these infections faces multiple challenges, such as difficulties in early accurate diagnosis, and various controversies about the treatment plan, leading to poor overall diagnosis and treatment results. To address these issues, based on evidence-based medicine and principles with emphasis on scientific rigor, clinical applicability and innovation, the Trauma Branch of the Chinese Medical Association, Orthopedic Branch of the Chinese Medical Doctor Association, Orthopedics Branch of the Chinese Medical Association, and Trauma Orthopedics and Polytrauma Group of the Resuscitation and Emergency Committee of the Chinese Medical Doctor Association have collaboratively organized a panel of relevant experts to develop the Guideline for diagnosis and treatment of infection after internal fixation of closed lower limb fractures in adults ( version 2025). The guideline proposed 10 recommendations, aiming to provide a foundation for standardized diagnosis and treatment of postoperative infection in adults with closed lower limb fractures.

Result Analysis
Print
Save
E-mail